Pasar al contenido principal
Main navigation
About us
About us
Our work
Rationale
IDDO Team
Contact us
Our partners
Governance
Governance
IDDO Board
Data Access Committee
Data reuse
Data reuse
Contributing data
Accessing data
IDDO legal and regulatory documentation
IDDO data sharing registrations
Frequently Asked Questions
Research themes
Research themes
WWARN
COVID-19
Ebola
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Febrile illness
Scrub typhus
Trachoma
Other diseases
Research
Research
Malaria Tracking Resistance
Malaria Clinical Trials Toolkit
COVID-19 LSR Tool
VL Tool
Medicine Quality Monitoring Globe
Medicine Quality Scientific Literature Surveyor
Febrile Illness Surveyor
Publications
Tools & resources
News
User account menu
Iniciar sesión
Register
Contact
Bandwidth
Alto
Bajo
Language switcher
English
Français
Español
Toggle navigation
About us
About us
Overview
Our partners
Team
Governance
Governance
COVID-19 Data Access Committee
Data reuse
Accessing data
Contributing data
Benefits of data reuse
Research
Approved uses of platform data
Living systematic review trials
Medicine Quality monitoring
Publications
Tools and resources
News
Search
Search
Search
COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
The Lancet Global Health
Published
9 Abr 2020
Authors
Paul N Newton, Katherine C Bond, on behalf of 53 signatories from 20 countries
DOI
https://doi.org/10.1016/S2214-109X(20)30136-4
Read here
